These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16289392

  • 1. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
    Yuan Z, White RJ.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1042-7. PubMed ID: 16289392
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
    Chikhi A, Bensegueni A, Boulahrouf A, Bencharif M.
    In Silico Biol; 2006 Mar 30; 6(5):459-66. PubMed ID: 17274774
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
    Boularot A, Giglione C, Artaud I, Meinnel T.
    Curr Opin Investig Drugs; 2004 Aug 30; 5(8):809-22. PubMed ID: 15600237
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
    Goemaere E, Melet A, Larue V, Lieutaud A, Alves de Sousa R, Chevalier J, Yimga-Djapa L, Giglione C, Huguet F, Alimi M, Meinnel T, Dardel F, Artaud I, Pagès JM.
    J Antimicrob Chemother; 2012 Jun 30; 67(6):1392-400. PubMed ID: 22378679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT, Hu X, Colton C, Chakrabarti R, Zhu MX, Pei D.
    Biochemistry; 2003 Aug 26; 42(33):9952-8. PubMed ID: 12924944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B, Gong W, Rajagopalan PT, Zhou Y, Pei D, Chan MK.
    Biochemistry; 1999 Apr 13; 38(15):4712-9. PubMed ID: 10200158
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S, Shi W, Xing D, Zhao Z, Lv F, Yang L, Yang Y, Hu W.
    Eur J Med Chem; 2014 Oct 30; 86():133-52. PubMed ID: 25151577
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK, Choi KH, Lee SJ, Suh SW, Kim BM, Lee BJ.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4317-9. PubMed ID: 20615695
    [Abstract] [Full Text] [Related]

  • 18. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
    Bingel-Erlenmeyer R, Kohler R, Kramer G, Sandikci A, Antolić S, Maier T, Schaffitzel C, Wiedmann B, Bukau B, Ban N.
    Nature; 2008 Mar 06; 452(7183):108-11. PubMed ID: 18288106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK, Green BG, Kozarich JW.
    Bioorg Chem; 2001 Aug 06; 29(4):211-22. PubMed ID: 16256693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.